aluates Reports

$ 0.0

Automative

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-16X12884

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Research Report 2023

BUY CHAPTERS

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Research Report 2025

Code: QYRE-Auto-16X12884

Report

April 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alivira Animal Health Ltd.

Excel Industries Ltd

FIS - Fabbrica Italiana Sintetici S.p.A

Ofichem Group

Menadiona

Suanfarma

Siflon Drugs

Chempro Pharma Private Ltd.

Vetpharma (Insud Pharma, S.L.U)

Hikal

HuBei Masteam Bio-tech

Hunan Huateng Pharmaceutical

Jiangsu Rivocean

Qilu Pharma Spain, S.A.

Nissan Chemical

Shaanxi Dideu Group

Taizhou Crene Biotechnology

Zhejiang Gihi Chemicals

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size

The global market for Veterinary Active Pharmaceutical Ingredients Manufacturing was valued at US$ 7183 million in the year 2024 and is projected to reach a revised size of US$ 11350 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market

Veterinary active pharmaceutical ingredients manufacturing are made by more than one reaction from raw materials. It generally becomes an active pharmaceutical ingredients through the chemical compounds. The active pharmaceutical ingredients manufacturing utilize specific standards for determining how strong it is in every drug.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 125%.

This report aims to provide a comprehensive presentation of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Active Pharmaceutical Ingredients Manufacturing.

The Veterinary Active Pharmaceutical Ingredients Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Active Pharmaceutical Ingredients Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Veterinary Active Pharmaceutical Ingredients Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report

Report Metric	Details
Report Name	Veterinary Active Pharmaceutical Ingredients Manufacturing Market
Accounted market size in year	US$ 7183 million
Forecasted market size in 2031	US$ 11350 million
CAGR	6.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antiparasitic Anti-infectives NSAIDs Others
Segment by Application	Companion Animals Production/Food Animals
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alivira Animal Health Ltd., Chempro Pharma Private Ltd., Excel Industries Ltd., FIS - Fabbrica Italiana Sintetici S.p.A., HIKAL Ltd., HuBei Masteam Bio-tech, Hunan Huateng Pharmaceutical, Jiangsu Rivocean, Ofichem Group, Qilu Pharma Spain, S.A., Menadiona, Nissan Chemical, SUANFARMA, Siflon Drugs, Shaanxi Dideu Group, Taizhou Crene Biotechnology, Zhejiang Gihi Chemicals, Vetpharma (Insud Pharma, S.L.U)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Veterinary Active Pharmaceutical Ingredients Manufacturing Market growing?

Ans: The Veterinary Active Pharmaceutical Ingredients Manufacturing Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market size in 2031?

Ans: The Veterinary Active Pharmaceutical Ingredients Manufacturing Market size in 2031 will be US$ 11350 million.

What is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market report?

Ans: The main players in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market are Alivira Animal Health Ltd., Chempro Pharma Private Ltd., Excel Industries Ltd., FIS - Fabbrica Italiana Sintetici S.p.A., HIKAL Ltd., HuBei Masteam Bio-tech, Hunan Huateng Pharmaceutical, Jiangsu Rivocean, Ofichem Group, Qilu Pharma Spain, S.A., Menadiona, Nissan Chemical, SUANFARMA, Siflon Drugs, Shaanxi Dideu Group, Taizhou Crene Biotechnology, Zhejiang Gihi Chemicals, Vetpharma (Insud Pharma, S.L.U)

What are the Application segmentation covered in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market report?

Ans: The Applications covered in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market report are Companion Animals, Production/Food Animals

What are the Type segmentation covered in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market report?

Ans: The Types covered in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market report are Antiparasitic, Anti-infectives, NSAIDs, Others

Recommended Reports

Veterinary Healthcare

Animal Nutrition

Pet Pharmaceuticals

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antiparasitic

1.2.3 Anti-infectives

1.2.4 NSAIDs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Companion Animals

1.3.3 Production/Food Animals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Perspective (2020-2031)

2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Growth Trends by Region

2.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics

2.3.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends

2.3.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers

2.3.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges

2.3.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Revenue

3.1.1 Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue

3.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Ratio

3.4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue in 2024

3.5 Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing Head office and Area Served

3.6 Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Product and Application

3.7 Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Veterinary Active Pharmaceutical Ingredients Manufacturing Breakdown Data by Type

4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Type (2026-2031)

5 Veterinary Active Pharmaceutical Ingredients Manufacturing Breakdown Data by Application

5.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)

6.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)

6.4 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)

7.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)

7.4 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)

9.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alivira Animal Health Ltd.

11.1.1 Alivira Animal Health Ltd. Company Details

11.1.2 Alivira Animal Health Ltd. Business Overview

11.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.1.4 Alivira Animal Health Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.1.5 Alivira Animal Health Ltd. Recent Development

11.2 Chempro Pharma Private Ltd.

11.2.1 Chempro Pharma Private Ltd. Company Details

11.2.2 Chempro Pharma Private Ltd. Business Overview

11.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.2.4 Chempro Pharma Private Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.2.5 Chempro Pharma Private Ltd. Recent Development

11.3 Excel Industries Ltd.

11.3.1 Excel Industries Ltd. Company Details

11.3.2 Excel Industries Ltd. Business Overview

11.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.3.4 Excel Industries Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.3.5 Excel Industries Ltd. Recent Development

11.4 FIS - Fabbrica Italiana Sintetici S.p.A.

11.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Details

11.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Business Overview

11.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Development

11.5 HIKAL Ltd.

11.5.1 HIKAL Ltd. Company Details

11.5.2 HIKAL Ltd. Business Overview

11.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.5.4 HIKAL Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.5.5 HIKAL Ltd. Recent Development

11.6 HuBei Masteam Bio-tech

11.6.1 HuBei Masteam Bio-tech Company Details

11.6.2 HuBei Masteam Bio-tech Business Overview

11.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.6.4 HuBei Masteam Bio-tech Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.6.5 HuBei Masteam Bio-tech Recent Development

11.7 Hunan Huateng Pharmaceutical

11.7.1 Hunan Huateng Pharmaceutical Company Details

11.7.2 Hunan Huateng Pharmaceutical Business Overview

11.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.7.4 Hunan Huateng Pharmaceutical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.7.5 Hunan Huateng Pharmaceutical Recent Development

11.8 Jiangsu Rivocean

11.8.1 Jiangsu Rivocean Company Details

11.8.2 Jiangsu Rivocean Business Overview

11.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.8.4 Jiangsu Rivocean Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.8.5 Jiangsu Rivocean Recent Development

11.9 Ofichem Group

11.9.1 Ofichem Group Company Details

11.9.2 Ofichem Group Business Overview

11.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.9.4 Ofichem Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.9.5 Ofichem Group Recent Development

11.10 Qilu Pharma Spain, S.A.

11.10.1 Qilu Pharma Spain, S.A. Company Details

11.10.2 Qilu Pharma Spain, S.A. Business Overview

11.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.10.4 Qilu Pharma Spain, S.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.10.5 Qilu Pharma Spain, S.A. Recent Development

11.11 Menadiona

11.11.1 Menadiona Company Details

11.11.2 Menadiona Business Overview

11.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.11.4 Menadiona Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.11.5 Menadiona Recent Development

11.12 Nissan Chemical

11.12.1 Nissan Chemical Company Details

11.12.2 Nissan Chemical Business Overview

11.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.12.4 Nissan Chemical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.12.5 Nissan Chemical Recent Development

11.13 SUANFARMA

11.13.1 SUANFARMA Company Details

11.13.2 SUANFARMA Business Overview

11.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.13.4 SUANFARMA Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.13.5 SUANFARMA Recent Development

11.14 Siflon Drugs

11.14.1 Siflon Drugs Company Details

11.14.2 Siflon Drugs Business Overview

11.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.14.4 Siflon Drugs Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.14.5 Siflon Drugs Recent Development

11.15 Shaanxi Dideu Group

11.15.1 Shaanxi Dideu Group Company Details

11.15.2 Shaanxi Dideu Group Business Overview

11.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.15.4 Shaanxi Dideu Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.15.5 Shaanxi Dideu Group Recent Development

11.16 Taizhou Crene Biotechnology

11.16.1 Taizhou Crene Biotechnology Company Details

11.16.2 Taizhou Crene Biotechnology Business Overview

11.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.16.4 Taizhou Crene Biotechnology Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.16.5 Taizhou Crene Biotechnology Recent Development

11.17 Zhejiang Gihi Chemicals

11.17.1 Zhejiang Gihi Chemicals Company Details

11.17.2 Zhejiang Gihi Chemicals Business Overview

11.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.17.4 Zhejiang Gihi Chemicals Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.17.5 Zhejiang Gihi Chemicals Recent Development

11.18 Vetpharma (Insud Pharma, S.L.U)

11.18.1 Vetpharma (Insud Pharma, S.L.U) Company Details

11.18.2 Vetpharma (Insud Pharma, S.L.U) Business Overview

11.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction

11.18.4 Vetpharma (Insud Pharma, S.L.U) Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

11.18.5 Vetpharma (Insud Pharma, S.L.U) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alivira Animal Health Ltd.

Excel Industries Ltd

FIS - Fabbrica Italiana Sintetici S.p.A

Ofichem Group

Menadiona

Suanfarma

Siflon Drugs

Chempro Pharma Private Ltd.

Vetpharma (Insud Pharma, S.L.U)

Hikal

HuBei Masteam Bio-tech

Hunan Huateng Pharmaceutical

Jiangsu Rivocean

Qilu Pharma Spain, S.A.

Nissan Chemical

Shaanxi Dideu Group

Taizhou Crene Biotechnology

Zhejiang Gihi Chemicals

List of Tables

Table 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antiparasitic

Table 3. Key Players of Anti-infectives

Table 4. Key Players of NSAIDs

Table 5. Key Players of Others

Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Region (2020-2025)

Table 10. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Region (2026-2031)

Table 12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends

Table 13. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers

Table 14. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges

Table 15. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints

Table 16. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Players (2020-2025)

Table 18. Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing as of 2024)

Table 19. Ranking of Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Headquarters and Area Served

Table 22. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Product and Application

Table 23. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Type (2020-2025)

Table 27. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Type (2026-2031)

Table 29. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Application (2020-2025)

Table 31. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Application (2026-2031)

Table 33. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Alivira Animal Health Ltd. Company Details

Table 49. Alivira Animal Health Ltd. Business Overview

Table 50. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 51. Alivira Animal Health Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 52. Alivira Animal Health Ltd. Recent Development

Table 53. Chempro Pharma Private Ltd. Company Details

Table 54. Chempro Pharma Private Ltd. Business Overview

Table 55. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 56. Chempro Pharma Private Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 57. Chempro Pharma Private Ltd. Recent Development

Table 58. Excel Industries Ltd. Company Details

Table 59. Excel Industries Ltd. Business Overview

Table 60. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 61. Excel Industries Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 62. Excel Industries Ltd. Recent Development

Table 63. FIS - Fabbrica Italiana Sintetici S.p.A. Company Details

Table 64. FIS - Fabbrica Italiana Sintetici S.p.A. Business Overview

Table 65. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 66. FIS - Fabbrica Italiana Sintetici S.p.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 67. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Development

Table 68. HIKAL Ltd. Company Details

Table 69. HIKAL Ltd. Business Overview

Table 70. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 71. HIKAL Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 72. HIKAL Ltd. Recent Development

Table 73. HuBei Masteam Bio-tech Company Details

Table 74. HuBei Masteam Bio-tech Business Overview

Table 75. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 76. HuBei Masteam Bio-tech Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 77. HuBei Masteam Bio-tech Recent Development

Table 78. Hunan Huateng Pharmaceutical Company Details

Table 79. Hunan Huateng Pharmaceutical Business Overview

Table 80. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 81. Hunan Huateng Pharmaceutical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 82. Hunan Huateng Pharmaceutical Recent Development

Table 83. Jiangsu Rivocean Company Details

Table 84. Jiangsu Rivocean Business Overview

Table 85. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 86. Jiangsu Rivocean Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 87. Jiangsu Rivocean Recent Development

Table 88. Ofichem Group Company Details

Table 89. Ofichem Group Business Overview

Table 90. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 91. Ofichem Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 92. Ofichem Group Recent Development

Table 93. Qilu Pharma Spain, S.A. Company Details

Table 94. Qilu Pharma Spain, S.A. Business Overview

Table 95. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 96. Qilu Pharma Spain, S.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 97. Qilu Pharma Spain, S.A. Recent Development

Table 98. Menadiona Company Details

Table 99. Menadiona Business Overview

Table 100. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 101. Menadiona Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 102. Menadiona Recent Development

Table 103. Nissan Chemical Company Details

Table 104. Nissan Chemical Business Overview

Table 105. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 106. Nissan Chemical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 107. Nissan Chemical Recent Development

Table 108. SUANFARMA Company Details

Table 109. SUANFARMA Business Overview

Table 110. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 111. SUANFARMA Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 112. SUANFARMA Recent Development

Table 113. Siflon Drugs Company Details

Table 114. Siflon Drugs Business Overview

Table 115. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 116. Siflon Drugs Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 117. Siflon Drugs Recent Development

Table 118. Shaanxi Dideu Group Company Details

Table 119. Shaanxi Dideu Group Business Overview

Table 120. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 121. Shaanxi Dideu Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 122. Shaanxi Dideu Group Recent Development

Table 123. Taizhou Crene Biotechnology Company Details

Table 124. Taizhou Crene Biotechnology Business Overview

Table 125. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 126. Taizhou Crene Biotechnology Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 127. Taizhou Crene Biotechnology Recent Development

Table 128. Zhejiang Gihi Chemicals Company Details

Table 129. Zhejiang Gihi Chemicals Business Overview

Table 130. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 131. Zhejiang Gihi Chemicals Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 132. Zhejiang Gihi Chemicals Recent Development

Table 133. Vetpharma (Insud Pharma, S.L.U) Company Details

Table 134. Vetpharma (Insud Pharma, S.L.U) Business Overview

Table 135. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product

Table 136. Vetpharma (Insud Pharma, S.L.U) Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025) & (US$ Million)

Table 137. Vetpharma (Insud Pharma, S.L.U) Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Picture

Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Antiparasitic Features

Figure 5. Anti-infectives Features

Figure 6. NSAIDs Features

Figure 7. Others Features

Figure 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Application: 2024 VS 2031

Figure 10. Companion Animals Case Studies

Figure 11. Production/Food Animals Case Studies

Figure 12. Veterinary Active Pharmaceutical Ingredients Manufacturing Report Years Considered

Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Region: 2024 VS 2031

Figure 16. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Players in 2024

Figure 17. Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue in 2024

Figure 19. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Country (2020-2031)

Figure 21. United States Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Country (2020-2031)

Figure 25. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Region (2020-2031)

Figure 33. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Country (2020-2031)

Figure 41. Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Country (2020-2031)

Figure 45. Turkey Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Alivira Animal Health Ltd. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 49. Chempro Pharma Private Ltd. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 50. Excel Industries Ltd. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 51. FIS - Fabbrica Italiana Sintetici S.p.A. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 52. HIKAL Ltd. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 53. HuBei Masteam Bio-tech Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 54. Hunan Huateng Pharmaceutical Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 55. Jiangsu Rivocean Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 56. Ofichem Group Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 57. Qilu Pharma Spain, S.A. Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 58. Menadiona Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 59. Nissan Chemical Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 60. SUANFARMA Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 61. Siflon Drugs Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 62. Shaanxi Dideu Group Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 63. Taizhou Crene Biotechnology Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 64. Zhejiang Gihi Chemicals Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 65. Vetpharma (Insud Pharma, S.L.U) Revenue Growth Rate in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Veterinary API Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary APIs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Intermediates Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025

Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antimicrobial Ingredients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotics Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Drug Premix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Continuous Manufacturing in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotics Active Pharmaceutical Ingredient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Fine Chemicals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Products for Livestock Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025

Veterinary Pharmaceutical Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions